Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;35(6):1318-24.
doi: 10.1016/j.neurobiolaging.2013.12.030. Epub 2013 Dec 27.

Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals

Affiliations

Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals

Ricardo S Osorio et al. Neurobiol Aging. 2014 Jun.

Abstract

Previous studies have suggested a link between sleep disordered breathing (SDB) and dementia risk. In the present study, we analyzed the relationship between SDB severity, cerebrospinal fluid (CSF) Alzheimer's disease-biomarkers, and the ApoE alleles. A total of 95 cognitively normal elderly participants were analyzed for SDB severity, CSF measures of phosphorylated-tau (p-tau), total-tau (t-tau), and amyloid beta 42 (Aβ-42), as well as ApoE allele status. In ApoE3+ subjects, significant differences were found between sleep groups for p-tau (F[df2] = 4.3, p = 0.017), and t-tau (F[df2] = 3.3, p = 0.043). Additionally, among ApoE3+ subjects, the apnea and/or hypopnea with 4% O2-desaturation index was positively correlated with p-tau (r = 0.30, p = 0.023), t-tau (r = 0.31, p = 0.021), and Aβ-42 (r = 0.31, p = 0.021). In ApoE2+ subjects, the apnea and/or hypopnea with 4% O2-desaturation index was correlated with lower levels of CSF Aβ-42 (r = -0.71, p = 0.004), similarly to ApoE4+ subjects where there was also a trend toward lower CSF Aβ-42 levels. Our observations suggest that there is an association between SDB and CSF Alzheimer's disease-biomarkers in cognitively normal elderly individuals. Existing therapies for SDB such as continuous positive airway pressure could delay the onset to mild cognitive impairment or dementia in normal elderly individuals.

Keywords: Alzheimer's disease; Amyloid beta 42; ApoE; Biomarkers; CSF; Cerebral amyloid angiopathy; Elderly; Sleep-disordered breathing; p-tau.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Graphs of AHI4% and CSF Aβ42 for all subjects (n=95), ApoE 2+ subjects (n=14), ApoE3+ subjects (n=56), and ApoE4+ subjects (n=29). Y Axis: Natural Log of AHI4%; X Axis: CSF levels of Aβ42.
Figure 2
Figure 2
Graphs of AHI4% and Natural Log of CSF P-Tau for all subjects (n=95), ApoE 2+ subjects (n=14), ApoE3+ subjects (n=56), and ApoE4+ subjects (n=29). Y Axis: Natural Log of AHI4%; X Axis: Natural Log of CSF levels of P-Tau
Figure 3
Figure 3
Graphs of AHI4% and Natural Log of CSF T-Tau for all subjects (n=95), ApoE 2+ subjects (n=14), ApoE3+ subjects (n=56), and ApoE4+ subjects (n=29). Y Axis: Natural Log of AHI4%; X Axis: Natural Log of CSF levels of T-Tau

Similar articles

Cited by

References

    1. Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J Am Geriatr Soc. 2008;56:2076–81. - PMC - PubMed
    1. Ayappa I, Norman RG, Seelall V, Rapoport DM. Validation of a self-applied unattended monitor for sleep disordered breathing. J Clin Sleep Med. 2008;4:26–37. - PMC - PubMed
    1. Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, Lampe J, Kahn SE, Craft S. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol. 2011;68:743–52. - PMC - PubMed
    1. Blennow K, Zetterberg H. The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease. Med Clin North Am. 2013;97:369–76. - PubMed
    1. Braak H, Braak E. Staging of alzheimer's disease-related neurofibrillary changes. Neurobiology of Aging. 1995;16:271–8. - PubMed

Publication types

MeSH terms